Kidney Transplantation in the United States: Economic Burden and Recent Trends Analysis

Abstract

Objective

As kidney transplant is the preferred mode of management of advanced kidney disease and economic trends for kidney transplant procedures are not well known, data were analyzed to assess these trends.

Data Source

Annual data for 1998 to 2008 from the Nationwide Inpatient Sample, Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality were used to analyze characteristics of patients discharged from hospitals in the United States with kidney transplant as the primary procedure.

Data Synthesis/Results

The population more than 65 years old had the most significant increase in hospitalizations for kidney transplant procedures (P < .01). The mean length of stay decreased by 2.8 days over the period studied (P = .02). Mean hospital charge increased despite a decrease in length of stay resulting in a 225% increase in charge per day of hospitalization, from $6907 in 1998 to $22484 in 2008. The national aggregate hospital charges for kidney transplant procedures rose from $0.9 billion in 1998 to $3.1 billion in 2008. Kidney transplant was overall ranked sixth by mean cost per hospitalization and ranked seventh by mean charge per hospitalization among the Clinical Classification Software's Services and Procedures in this database in 2008.

Conclusion

Despite shorter hospital stays, the economic burden of kidney transplants increased from 1998 to 2008.

Get full access to this article

View all access options for this article.

References

Barry

. Successful homotransplantation of the human kidney between identical twins. 1956. J Urol. 2002;167(2 pt 2):830.

Laupacis

Keown

Pus

. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996; 50(1):235–242.

Ojo

Port

Wolfe

Mauger

Williams

Berling

. Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am J Kidney Dis. 1994;24(1):59–64.

Oniscu

Brown

Forsythe

. Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol. 2005;16(6):1859–1865.

Eggers

Kucken

. Cost issues in transplantation. Surg Clin North Am. 1994;74(5): 1259–1267.

Trilla

Bertran

Prat

Bruni

Roig

Asenjo

. Cost analysis of cardiac transplantation in a Spanish hospital [in Spanish]. Med Clin (Bare). 2006;126(10):373–375.

Levy

Sobolev

James

. The costs of change: Direct medical costs of solid organ transplantation in British Columbia, Canada, 1995–2003. Value Health. 2009;12(2):282–292.

HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 1998–2008. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed July 21, 2012.

Clinical Classifications Software for Services and Procedures (CCS-Services and Procedures), HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 1998–2008. Agency for Healthcare Research and Quality. Rockville, MD. http://hcupnet.ahrq.gov/HCUPnetjsp?Id=E2478DlB7F004BD5&Form=SelALLLISTED&JS =Y&Action=%3E%3ENext%3E%3E&_ALLLISTED=No. Accessed July 21, 2012.

10.

United Network for Organ Sharing, http://optn.transplant.hrsa.gov/latestData/rptData.asp. Accessed July 21, 2012.

11.

Perico

Remuzzi

. Prevention of transplant rejection: Current treatment guidelines and future developments. Drugs. 1997; 54(4):533–570.

12.

Clark

. Monitoring antithymocyte globulin in renal transplantation. Ann R Coll Surg Engl. 1996;78(6):536–540.

13.

Sommer

Henry

Ferguson

. Sequential antilymphoblast globulin and cyclosporine for renal transplantation. Transplantation. 1987;43(1):85–90.

14.

Scherer

Banas

Mantouvalou

. Current concepts and perspectives of immunosuppression in organ transplantation. Langenbecks Arch Surg. 2007;392(5):511–523.

15.

Gaber

Knight

Patel

Gaber

. A review of the evidence for use of thymoglobulin induction in renal transplantation. Transplant Proc. 2010;42(5): 1395–1400.

16.

Noble

Faulds

. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs. 1998;56(1):115–146.

17.

Sun

Wagener

Singh

. Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: A systematic review. Am J Transplant. 2008;8(10): 2111–2118.

18.

Weikert

Blumberg

. Viral infection after renal transplantation: Surveillance and management. Clin J Am Soc Nephrol. 2008;3(suppl 2):S76–86.

19.

Pascual

Zamora

Pirsch

. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis. 2008;52(3):553–586.

20.

US Department of Health and Human Services by the United Network for Organ Sharing-Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov/latestData/rptData.asp. Accessed July 21, 2012.

21.

Hernandez

Rufino

Gonzalez-Posada

. Predicting delayed graft function and mortality in kidney transplantation. Transplant Rev (Orlando). 2008;22(1):21–26.

22.

Saidi

Elias

Kawai

. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: Realities and costs. Am J Transplant. 2007;7(12):2769–2774.